Takeda Pharmaceutical (TAK) Receivables (2017 - 2026)
Takeda Pharmaceutical (TAK) reported Receivables of $5.84 billion for the quarter ended Jun 30, 2026, up 26.9% from $4.6 billion a year earlier and up 8.4% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Receivables (2017 - 2026) Analysis & Trends
As of Mar 31, 2026, Takeda Pharmaceutical posted Receivables of $6.49 billion, up 28.3% from the prior year.
- Receivables has a five-year compound annual growth rate of -2.7% (years ended Mar 2021 to Mar 2026).
- By year, Receivables came in at $5.06 billion in the year ended Mar 31, 2025 (+1.6%), $4.98 billion in the year ended Mar 31, 2024 (-0.2%), $4.99 billion in the year ended Mar 31, 2023 (-21.1%) and $6.33 billion in the year ended Mar 31, 2022 (-14.9%).
- The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Receivables since the quarter ended Jun 30, 2022.
- Year over year, Receivables has now increased in each of the last three quarters, with growth averaging 2.6% over the last eight quarters.
- The high point for year-over-year Receivables in five years was the quarter ended Jun 30, 2026 (growth of 26.9%); the low point was the quarter ended Mar 31, 2022 (a decline of 17.9%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $5.38 billion (quarter ended Mar 31, 2026), $4.79 billion (quarter ended Dec 31, 2025) and $4.68 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Takeda Pharmaceutical | 2.74 Bn | -23.77 Bn | 5.10 Bn | 5.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.84 Bn |
| Mar 31, 2026 | 5.38 Bn |
| Dec 31, 2025 | 4.79 Bn |
| Sep 30, 2025 | 4.68 Bn |
| Jun 30, 2025 | 4.60 Bn |
| Mar 31, 2025 | 5.05 Bn |
| Dec 31, 2024 | 4.68 Bn |
| Sep 30, 2024 | 4.70 Bn |
| Jun 30, 2024 | 4.85 Bn |
| Mar 31, 2024 | 4.85 Bn |
| Dec 31, 2023 | 4.85 Bn |
| Sep 30, 2023 | 5.23 Bn |
| Jun 30, 2023 | 5.79 Bn |
| Mar 31, 2023 | 5.10 Bn |
| Dec 31, 2022 | 5.01 Bn |
| Sep 30, 2022 | 5.50 Bn |
| Jun 30, 2022 | 5.89 Bn |
| Mar 31, 2022 | 6.11 Bn |
| Jun 30, 2021 | 7.56 Bn |
| Mar 31, 2021 | 7.45 Bn |
API Access
Takeda Pharmaceutical Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();